Φορτώνει......
Evaluation of Epic® label-free technology to quantify functional recombinant hemagglutinin
BACKGROUND: Alternative methods are being sought to measure the potency of influenza vaccines. Label-free technologies that do not require the use of hemagglutinin (HA)-specific antisera are particularly attractive as the preparation of antiserum delays availability of potency reagents. The objectiv...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Biol Proced Online |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4359790/ https://ncbi.nlm.nih.gov/pubmed/25774096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12575-015-0019-5 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|